During the recent World Pancreatic Cancer Coalition (WPCC) member call, Dr. Anna Berkenblit, Chief Scientific and Medical Officer at PanCAN, delivered a comprehensive overview of the current state of pancreatic cancer research.

During the latest I-PCC symposium, we officially opened the network to “Affiliated Labs”, laboratories whose principal investigators or teams actively participate in or contribute to I-PCC, and are distinct from the “Founder Labs”.

The second symposium of the Italian Pancreatic Cancer Community (I-PCC) was held on June 4th 2025 in the beautiful setting of CNR Nanotec in Lecce, an exceptional venue that welcomed over 130 participants and featured 21 scientific presentations, many of which were delivered by young researchers, PhD students, and postdocs. The event was a resounding success, reaffirming the energy and cohesion of a growing community deeply committed to the fight against pancreatic cancer.

The Italian Pancreatic Cancer Community (I-PCC) is an online platform that connects Italian scientists working in basic and translational pancreatic cancer research. Established in 2021 with the support of Fondazione Nadia Valsecchi, a non-profit organization with over 10 years of experience supporting research, patients, families, and public awareness, the I-PCC aims to foster collaboration and accelerate progress in the fight against pancreatic cancer.